Effect of lysoplatelet-activating factor on human sperm fertilizing ability

To evaluate the penetration rates in the hamster zona-free oocyte sperm penetration assay (SPA) after exposure of spermatozoa to lysoplatelet-activating factor (LPAF) and lysophosphatidyl choline (LPC). Washed human spermatozoa were exposed to 100μM of LPAF or LPC, followed by the assessment of thei...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fertility and sterility 1993-04, Vol.59 (4), p.863-868
Hauptverfasser: Lachapelle, Marie-Hélène, Bouzayen, Renda, Langlais, Jean, Jarvi, Keith, Bourque, Jacques, Miron, Pierre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 868
container_issue 4
container_start_page 863
container_title Fertility and sterility
container_volume 59
creator Lachapelle, Marie-Hélène
Bouzayen, Renda
Langlais, Jean
Jarvi, Keith
Bourque, Jacques
Miron, Pierre
description To evaluate the penetration rates in the hamster zona-free oocyte sperm penetration assay (SPA) after exposure of spermatozoa to lysoplatelet-activating factor (LPAF) and lysophosphatidyl choline (LPC). Washed human spermatozoa were exposed to 100μM of LPAF or LPC, followed by the assessment of their fertilizing ability using the SPA. The percentage of penetration, the sperm binding in the SPA, the percentage of motile spermatozoa, and the acrosome reaction rates were quantified. Private research and university laboratories. Fresh and frozen semen samples from fertile donors with proven fertility were used as well as fresh semen from infertile patients attending a fertility clinic. All the infertile patients had abnormal semen analysis. Human spermatozoa were incubated for 90 minutes in the presence or absence of LPAF or LPC at 100μM with 0.3% albumin in Ham’s F-10 (GIBCO, Dorval, Quebec, Canada), and their fertilizing ability was evaluated using the SPA. The effect of these lysophospholipids on the percentage of acrosome reaction was evaluated with a fluorescent microscopy technique. The penetration rates of the SPA in male factor increased significantly from 3%±6% with controls to 19%±9% and 34%±22% after incubation with LPC and LPAF, respectively. Sperm-oocyte binding was not significantly increased in this group. Sperm penetration assay penetration rates were also increased in fertile cryopreserved spermatozoa with LPC and LPAF. In this group, the acrosome reaction was significantly increased from 2%±1% in controls to 10%±6% and 8%±3% after incubation with LPC and LPAF, respectively. Lysoplatelet-activating factor and LPC independently increased the penetration rate of spermatozoa and the percentage of acrosome reaction. Lysophosphatidylcholine and LPAF may be beneficial in the treatment of spermatozoa with male factor infertility and may increase fertilization rates in IVF.
doi_str_mv 10.1016/S0015-0282(16)55873-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75649663</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028216558737</els_id><sourcerecordid>75649663</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-3377a938d55fb52b18afaac7d859487d7c4bf0de0502d02490a84b01e2ace60b3</originalsourceid><addsrcrecordid>eNqFkUtPHDEMgKMKRBfan4A0B1SVw4AzM3nMqUKIl0Di0PYceTJOm2oeS5JFWn59s-xqr5xsy5-d6DNjpxwuOHB5-ROAixIqXX3n8lwIrepSfWILLoQshRT1AVvskc_sOMZ_ACC5qo7YkW6EFtAu2OONc2RTMbtiWMd5OWCigVKJNvlXTH76U7icz6GYp-LvasSpiEsKY-EoJD_4tw2BXc7S-gs7dDhE-rqLJ-z37c2v6_vy6fnu4frqqbRNLVNZ10phW-teCNeJquMaHaJVvRZto1WvbNM56AkEVD1UTQuomw44VWhJQlefsG_bvcswv6woJjP6aGkYcKJ5FY0SsmmlrDMotqANc4yBnFkGP2JYGw5mI9G8SzQbQyZX7xKNynOnuwdW3Uj9fmpnLffPdn2MFgcXcLI-7rFGKshHyNiPLUZZxqunYKL1NFnqfcjOTT_7Dz7yH5iIjoM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75649663</pqid></control><display><type>article</type><title>Effect of lysoplatelet-activating factor on human sperm fertilizing ability</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Lachapelle, Marie-Hélène ; Bouzayen, Renda ; Langlais, Jean ; Jarvi, Keith ; Bourque, Jacques ; Miron, Pierre</creator><creatorcontrib>Lachapelle, Marie-Hélène ; Bouzayen, Renda ; Langlais, Jean ; Jarvi, Keith ; Bourque, Jacques ; Miron, Pierre</creatorcontrib><description>To evaluate the penetration rates in the hamster zona-free oocyte sperm penetration assay (SPA) after exposure of spermatozoa to lysoplatelet-activating factor (LPAF) and lysophosphatidyl choline (LPC). Washed human spermatozoa were exposed to 100μM of LPAF or LPC, followed by the assessment of their fertilizing ability using the SPA. The percentage of penetration, the sperm binding in the SPA, the percentage of motile spermatozoa, and the acrosome reaction rates were quantified. Private research and university laboratories. Fresh and frozen semen samples from fertile donors with proven fertility were used as well as fresh semen from infertile patients attending a fertility clinic. All the infertile patients had abnormal semen analysis. Human spermatozoa were incubated for 90 minutes in the presence or absence of LPAF or LPC at 100μM with 0.3% albumin in Ham’s F-10 (GIBCO, Dorval, Quebec, Canada), and their fertilizing ability was evaluated using the SPA. The effect of these lysophospholipids on the percentage of acrosome reaction was evaluated with a fluorescent microscopy technique. The penetration rates of the SPA in male factor increased significantly from 3%±6% with controls to 19%±9% and 34%±22% after incubation with LPC and LPAF, respectively. Sperm-oocyte binding was not significantly increased in this group. Sperm penetration assay penetration rates were also increased in fertile cryopreserved spermatozoa with LPC and LPAF. In this group, the acrosome reaction was significantly increased from 2%±1% in controls to 10%±6% and 8%±3% after incubation with LPC and LPAF, respectively. Lysoplatelet-activating factor and LPC independently increased the penetration rate of spermatozoa and the percentage of acrosome reaction. Lysophosphatidylcholine and LPAF may be beneficial in the treatment of spermatozoa with male factor infertility and may increase fertilization rates in IVF.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/S0015-0282(16)55873-7</identifier><identifier>PMID: 8458509</identifier><identifier>CODEN: FESTAS</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acrosome - drug effects ; Acrosome - physiology ; Animals ; asthenozoospermia ; Biological and medical sciences ; Birth control ; Cricetinae ; Female ; Fertilization in Vitro ; fertilizing ability ; Gynecology. Andrology. Obstetrics ; Humans ; IVF ; lysophosphatidyl choline ; Lysophosphatidylcholines - pharmacology ; Lysoplatelet-activating factor ; Male ; Medical sciences ; Mesocricetus ; Platelet Activating Factor - analogs &amp; derivatives ; Platelet Activating Factor - pharmacology ; Sperm Motility ; Sperm-Ovum Interactions - drug effects ; Sterility. Assisted procreation</subject><ispartof>Fertility and sterility, 1993-04, Vol.59 (4), p.863-868</ispartof><rights>1993 American Society for Reproductive Medicine</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-3377a938d55fb52b18afaac7d859487d7c4bf0de0502d02490a84b01e2ace60b3</citedby><cites>FETCH-LOGICAL-c436t-3377a938d55fb52b18afaac7d859487d7c4bf0de0502d02490a84b01e2ace60b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0015-0282(16)55873-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4670556$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8458509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lachapelle, Marie-Hélène</creatorcontrib><creatorcontrib>Bouzayen, Renda</creatorcontrib><creatorcontrib>Langlais, Jean</creatorcontrib><creatorcontrib>Jarvi, Keith</creatorcontrib><creatorcontrib>Bourque, Jacques</creatorcontrib><creatorcontrib>Miron, Pierre</creatorcontrib><title>Effect of lysoplatelet-activating factor on human sperm fertilizing ability</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>To evaluate the penetration rates in the hamster zona-free oocyte sperm penetration assay (SPA) after exposure of spermatozoa to lysoplatelet-activating factor (LPAF) and lysophosphatidyl choline (LPC). Washed human spermatozoa were exposed to 100μM of LPAF or LPC, followed by the assessment of their fertilizing ability using the SPA. The percentage of penetration, the sperm binding in the SPA, the percentage of motile spermatozoa, and the acrosome reaction rates were quantified. Private research and university laboratories. Fresh and frozen semen samples from fertile donors with proven fertility were used as well as fresh semen from infertile patients attending a fertility clinic. All the infertile patients had abnormal semen analysis. Human spermatozoa were incubated for 90 minutes in the presence or absence of LPAF or LPC at 100μM with 0.3% albumin in Ham’s F-10 (GIBCO, Dorval, Quebec, Canada), and their fertilizing ability was evaluated using the SPA. The effect of these lysophospholipids on the percentage of acrosome reaction was evaluated with a fluorescent microscopy technique. The penetration rates of the SPA in male factor increased significantly from 3%±6% with controls to 19%±9% and 34%±22% after incubation with LPC and LPAF, respectively. Sperm-oocyte binding was not significantly increased in this group. Sperm penetration assay penetration rates were also increased in fertile cryopreserved spermatozoa with LPC and LPAF. In this group, the acrosome reaction was significantly increased from 2%±1% in controls to 10%±6% and 8%±3% after incubation with LPC and LPAF, respectively. Lysoplatelet-activating factor and LPC independently increased the penetration rate of spermatozoa and the percentage of acrosome reaction. Lysophosphatidylcholine and LPAF may be beneficial in the treatment of spermatozoa with male factor infertility and may increase fertilization rates in IVF.</description><subject>Acrosome - drug effects</subject><subject>Acrosome - physiology</subject><subject>Animals</subject><subject>asthenozoospermia</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Cricetinae</subject><subject>Female</subject><subject>Fertilization in Vitro</subject><subject>fertilizing ability</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>IVF</subject><subject>lysophosphatidyl choline</subject><subject>Lysophosphatidylcholines - pharmacology</subject><subject>Lysoplatelet-activating factor</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mesocricetus</subject><subject>Platelet Activating Factor - analogs &amp; derivatives</subject><subject>Platelet Activating Factor - pharmacology</subject><subject>Sperm Motility</subject><subject>Sperm-Ovum Interactions - drug effects</subject><subject>Sterility. Assisted procreation</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtPHDEMgKMKRBfan4A0B1SVw4AzM3nMqUKIl0Di0PYceTJOm2oeS5JFWn59s-xqr5xsy5-d6DNjpxwuOHB5-ROAixIqXX3n8lwIrepSfWILLoQshRT1AVvskc_sOMZ_ACC5qo7YkW6EFtAu2OONc2RTMbtiWMd5OWCigVKJNvlXTH76U7icz6GYp-LvasSpiEsKY-EoJD_4tw2BXc7S-gs7dDhE-rqLJ-z37c2v6_vy6fnu4frqqbRNLVNZ10phW-teCNeJquMaHaJVvRZto1WvbNM56AkEVD1UTQuomw44VWhJQlefsG_bvcswv6woJjP6aGkYcKJ5FY0SsmmlrDMotqANc4yBnFkGP2JYGw5mI9G8SzQbQyZX7xKNynOnuwdW3Uj9fmpnLffPdn2MFgcXcLI-7rFGKshHyNiPLUZZxqunYKL1NFnqfcjOTT_7Dz7yH5iIjoM</recordid><startdate>19930401</startdate><enddate>19930401</enddate><creator>Lachapelle, Marie-Hélène</creator><creator>Bouzayen, Renda</creator><creator>Langlais, Jean</creator><creator>Jarvi, Keith</creator><creator>Bourque, Jacques</creator><creator>Miron, Pierre</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930401</creationdate><title>Effect of lysoplatelet-activating factor on human sperm fertilizing ability</title><author>Lachapelle, Marie-Hélène ; Bouzayen, Renda ; Langlais, Jean ; Jarvi, Keith ; Bourque, Jacques ; Miron, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-3377a938d55fb52b18afaac7d859487d7c4bf0de0502d02490a84b01e2ace60b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Acrosome - drug effects</topic><topic>Acrosome - physiology</topic><topic>Animals</topic><topic>asthenozoospermia</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Cricetinae</topic><topic>Female</topic><topic>Fertilization in Vitro</topic><topic>fertilizing ability</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>IVF</topic><topic>lysophosphatidyl choline</topic><topic>Lysophosphatidylcholines - pharmacology</topic><topic>Lysoplatelet-activating factor</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mesocricetus</topic><topic>Platelet Activating Factor - analogs &amp; derivatives</topic><topic>Platelet Activating Factor - pharmacology</topic><topic>Sperm Motility</topic><topic>Sperm-Ovum Interactions - drug effects</topic><topic>Sterility. Assisted procreation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lachapelle, Marie-Hélène</creatorcontrib><creatorcontrib>Bouzayen, Renda</creatorcontrib><creatorcontrib>Langlais, Jean</creatorcontrib><creatorcontrib>Jarvi, Keith</creatorcontrib><creatorcontrib>Bourque, Jacques</creatorcontrib><creatorcontrib>Miron, Pierre</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lachapelle, Marie-Hélène</au><au>Bouzayen, Renda</au><au>Langlais, Jean</au><au>Jarvi, Keith</au><au>Bourque, Jacques</au><au>Miron, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of lysoplatelet-activating factor on human sperm fertilizing ability</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>1993-04-01</date><risdate>1993</risdate><volume>59</volume><issue>4</issue><spage>863</spage><epage>868</epage><pages>863-868</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><coden>FESTAS</coden><abstract>To evaluate the penetration rates in the hamster zona-free oocyte sperm penetration assay (SPA) after exposure of spermatozoa to lysoplatelet-activating factor (LPAF) and lysophosphatidyl choline (LPC). Washed human spermatozoa were exposed to 100μM of LPAF or LPC, followed by the assessment of their fertilizing ability using the SPA. The percentage of penetration, the sperm binding in the SPA, the percentage of motile spermatozoa, and the acrosome reaction rates were quantified. Private research and university laboratories. Fresh and frozen semen samples from fertile donors with proven fertility were used as well as fresh semen from infertile patients attending a fertility clinic. All the infertile patients had abnormal semen analysis. Human spermatozoa were incubated for 90 minutes in the presence or absence of LPAF or LPC at 100μM with 0.3% albumin in Ham’s F-10 (GIBCO, Dorval, Quebec, Canada), and their fertilizing ability was evaluated using the SPA. The effect of these lysophospholipids on the percentage of acrosome reaction was evaluated with a fluorescent microscopy technique. The penetration rates of the SPA in male factor increased significantly from 3%±6% with controls to 19%±9% and 34%±22% after incubation with LPC and LPAF, respectively. Sperm-oocyte binding was not significantly increased in this group. Sperm penetration assay penetration rates were also increased in fertile cryopreserved spermatozoa with LPC and LPAF. In this group, the acrosome reaction was significantly increased from 2%±1% in controls to 10%±6% and 8%±3% after incubation with LPC and LPAF, respectively. Lysoplatelet-activating factor and LPC independently increased the penetration rate of spermatozoa and the percentage of acrosome reaction. Lysophosphatidylcholine and LPAF may be beneficial in the treatment of spermatozoa with male factor infertility and may increase fertilization rates in IVF.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8458509</pmid><doi>10.1016/S0015-0282(16)55873-7</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-0282
ispartof Fertility and sterility, 1993-04, Vol.59 (4), p.863-868
issn 0015-0282
1556-5653
language eng
recordid cdi_proquest_miscellaneous_75649663
source MEDLINE; ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Acrosome - drug effects
Acrosome - physiology
Animals
asthenozoospermia
Biological and medical sciences
Birth control
Cricetinae
Female
Fertilization in Vitro
fertilizing ability
Gynecology. Andrology. Obstetrics
Humans
IVF
lysophosphatidyl choline
Lysophosphatidylcholines - pharmacology
Lysoplatelet-activating factor
Male
Medical sciences
Mesocricetus
Platelet Activating Factor - analogs & derivatives
Platelet Activating Factor - pharmacology
Sperm Motility
Sperm-Ovum Interactions - drug effects
Sterility. Assisted procreation
title Effect of lysoplatelet-activating factor on human sperm fertilizing ability
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A19%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20lysoplatelet-activating%20factor%20on%20human%20sperm%20fertilizing%20ability&rft.jtitle=Fertility%20and%20sterility&rft.au=Lachapelle,%20Marie-H%C3%A9l%C3%A8ne&rft.date=1993-04-01&rft.volume=59&rft.issue=4&rft.spage=863&rft.epage=868&rft.pages=863-868&rft.issn=0015-0282&rft.eissn=1556-5653&rft.coden=FESTAS&rft_id=info:doi/10.1016/S0015-0282(16)55873-7&rft_dat=%3Cproquest_cross%3E75649663%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75649663&rft_id=info:pmid/8458509&rft_els_id=S0015028216558737&rfr_iscdi=true